Literature DB >> 33398279

Analyzing the vast coronavirus literature with CoronaCentral.

Jake Lever1, Russ B Altman1.   

Abstract

The global SARS-CoV-2 pandemic has caused a surge in research exploring all aspects of the virus and its effects on human health. The overwhelming rate of publications means that human researchers are unable to keep abreast of the research. To ameliorate this, we present the CoronaCentral resource which uses machine learning to process the research literature on SARS-CoV-2 along with articles on SARS-CoV and MERS-CoV. We break the literature down into useful categories and enable analysis of the contents, pace, and emphasis of research during the crisis. These categories cover therapeutics, forecasting as well as growing areas such as "Long Covid" and studies of inequality and misinformation. Using this data, we compare topics that appear in original research articles compared to commentaries and other article types. Finally, using Altmetric data, we identify the topics that have gained the most media attention. This resource, available at https://coronacentral.ai , is updated multiple times per day and provides an easy-to-navigate system to find papers in different categories, focussing on different aspects of the virus along with currently trending articles.

Entities:  

Year:  2020        PMID: 33398279      PMCID: PMC7781314          DOI: 10.1101/2020.12.21.423860

Source DB:  PubMed          Journal:  bioRxiv


  7 in total

1.  PubTator central: automated concept annotation for biomedical full text articles.

Authors:  Chih-Hsuan Wei; Alexis Allot; Robert Leaman; Zhiyong Lu
Journal:  Nucleic Acids Res       Date:  2019-07-02       Impact factor: 16.971

2.  Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.

Authors:  Adriaan H de Wilde; Dirk Jochmans; Clara C Posthuma; Jessika C Zevenhoven-Dobbe; Stefan van Nieuwkoop; Theo M Bestebroer; Bernadette G van den Hoogen; Johan Neyts; Eric J Snijder
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

3.  Keep up with the latest coronavirus research.

Authors:  Qingyu Chen; Alexis Allot; Zhiyong Lu
Journal:  Nature       Date:  2020-03       Impact factor: 49.962

4.  Rehabilitation and respiratory management in the acute and early post-acute phase. "Instant paper from the field" on rehabilitation answers to the COVID-19 emergency.

Authors:  Carlotte Kiekens; Paolo Boldrini; Arnaldo Andreoli; Renato Avesani; Federica Gamna; Maurizio Grandi; Francesco Lombardi; Mirco Lusuardi; Franco Molteni; Alberto Perboni; Stefano Negrini
Journal:  Eur J Phys Rehabil Med       Date:  2020-04-15       Impact factor: 2.874

5.  TREC-COVID: rationale and structure of an information retrieval shared task for COVID-19.

Authors:  Kirk Roberts; Tasmeer Alam; Steven Bedrick; Dina Demner-Fushman; Kyle Lo; Ian Soboroff; Ellen Voorhees; Lucy Lu Wang; William R Hersh
Journal:  J Am Med Inform Assoc       Date:  2020-07-01       Impact factor: 4.497

6.  Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).

Authors:  Nan Zhou; Ting Pan; Junsong Zhang; Qianwen Li; Xue Zhang; Chuan Bai; Feng Huang; Tao Peng; Jianhua Zhang; Chao Liu; Liang Tao; Hui Zhang
Journal:  J Biol Chem       Date:  2016-03-07       Impact factor: 5.157

7.  Machine Learning Maps Research Needs in COVID-19 Literature.

Authors:  Anhvinh Doanvo; Xiaolu Qian; Divya Ramjee; Helen Piontkivska; Angel Desai; Maimuna Majumder
Journal:  Patterns (N Y)       Date:  2020-09-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.